Atypical presentation of posterior reversible encephalopathy syndrome in a patient with sepsis

Abstract

Reversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomiting, seizure and visual loss. This neurologic syndrome was first described in 1996. Almost half of those patients had undergone bone marrow or solid organ transplant, and were under treatment with Cyclosporin or Tacrolimus. During the past decade its association with other co-morbidities including hypertensive encephalopathy, pre-eclamspisa/eclampsia, autoimmune diseases, post-streptococcal glomerulonephritis and Henoch-Schonlein has been shown.